Yao G - Search Results

1

Cdc42-driven endosomal cholesterol transport promotes collateral resistance in HER2-positive gastric cancer.

Liang B, Wu Q, Wang Y, Shi Y, Sun F, Huang Q, Li G, Liu Y, Zhang S, Xu X, Yao G, Peng J, Zhai X, Wu J, Tan Y, Wu Z, Zhou R, Li S, Wu J, Yang M, Liao W, Shi M. Liang B, et al. Among authors: yao g. Cancer Lett. 2024 Apr 10;587:216702. doi: 10.1016/j.canlet.2024.216702. Epub 2024 Feb 8. Cancer Lett. 2024. PMID: 38336288 Free article.

2

[Cytotoxic effect of photodynamic liposome gel combined with trastuzumab on drugresistant breast cancer cells in vitro].

Wang Y, Wen C, Ye J, Huang H, Zhang Y, Yuan H, Yao G, Yu M. Wang Y, et al. Among authors: yao g. Nan Fang Yi Ke Da Xue Xue Bao. 2021 Feb 25;41(2):164-172. doi: 10.12122/j.issn.1673-4254.2021.02.02. Nan Fang Yi Ke Da Xue Xue Bao. 2021. PMID: 33624588 Free PMC article. Chinese.

3

Disrupting Circadian Rhythm via the PER1-HK2 Axis Reverses Trastuzumab Resistance in Gastric Cancer.

Wang J, Huang Q, Hu X, Zhang S, Jiang Y, Yao G, Hu K, Xu X, Liang B, Wu Q, Ma Z, Wang Y, Wang C, Wu Z, Rong X, Liao W, Shi M. Wang J, et al. Among authors: yao g. Cancer Res. 2022 Apr 15;82(8):1503-1517. doi: 10.1158/0008-5472.CAN-21-1820. Cancer Res. 2022. PMID: 35255118 Free PMC article.

4

Targeting of mTORC2 prevents cell migration and promotes apoptosis in breast cancer.

Li H, Lin J, Wang X, Yao G, Wang L, Zheng H, Yang C, Jia C, Liu A, Bai X. Li H, et al. Among authors: yao g. Breast Cancer Res Treat. 2012 Aug;134(3):1057-66. doi: 10.1007/s10549-012-2036-2. Epub 2012 Apr 4. Breast Cancer Res Treat. 2012. PMID: 22476852

5

MT1-MMP in breast cancer: induction of VEGF-C correlates with metastasis and poor prognosis.

Yao G, He P, Chen L, Hu X, Gu F, Ye C. Yao G, et al. Cancer Cell Int. 2013 Oct 13;13(1):98. doi: 10.1186/1475-2867-13-98. Cancer Cell Int. 2013. PMID: 24119788 Free PMC article.

6

Short-duration versus 1-year adjuvant trastuzumab in early HER2 positive breast cancer: A meta-analysis of randomized controlled trials.

Chen L, Zhou W, Hu X, Yi M, Ye C, Yao G. Chen L, et al. Among authors: yao g. Cancer Treat Rev. 2019 May;75:12-19. doi: 10.1016/j.ctrv.2019.02.003. Epub 2019 Feb 28. Cancer Treat Rev. 2019. PMID: 30856373 Free article. Review.

7

NAP1L1 interacts with hepatoma-derived growth factor to recruit c-Jun inducing breast cancer growth.

Liu S, Zhang Y, Cui S, Song D, Li B, Chen Q, Yao G, Gong B. Liu S, et al. Among authors: yao g. Cancer Cell Int. 2021 Nov 13;21(1):605. doi: 10.1186/s12935-021-02301-3. Cancer Cell Int. 2021. PMID: 34774047 Free PMC article.

8

A Novel NIR Fluorescent Nanoprobe Targeting HER2-Positive Breast Cancer: Tra-TTR-A.

Chen M, Lin Z, Yao G, Hong X, Xue X, Chen L. Chen M, et al. Among authors: yao g. Bioinorg Chem Appl. 2021 Dec 30;2021:2495958. doi: 10.1155/2021/2495958. eCollection 2021. Bioinorg Chem Appl. 2021. Retraction in: Bioinorg Chem Appl. 2023 Dec 6;2023:9894803. doi: 10.1155/2023/9894803 PMID: 35003236 Free PMC article. Retracted.

9

Sauchinone inhibits breast cancer cell proliferation through regulating microRNA-148a-3p/HER-2 axis.

Hu X, Wang J, Shang P, Wang S, Chen L, Ye C, Yao G. Hu X, et al. Among authors: yao g. Thorac Cancer. 2023 May;14(13):1135-1144. doi: 10.1111/1759-7714.14834. Epub 2023 Mar 23. Thorac Cancer. 2023. PMID: 36959089 Free PMC article.

10

Correction to: NAP1L1 interacts with hepatoma-derived growth factor to recruit c-Jun inducing breast cancer growth.

Liu S, Zhang Y, Cui S, Song D, Li B, Chen Q, Yao G, Gong B. Liu S, et al. Among authors: yao g. Cancer Cell Int. 2022 Jan 15;22(1):26. doi: 10.1186/s12935-021-02437-2. Cancer Cell Int. 2022. PMID: 35033074 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,619 results

Search Page

Filters